Muge Akinci
United States
Abstract: ASSOCIATION OF TYPE 2 DIABETES TREATMENT STATUS WITH ALZHEIMER’S PATHOLOGY AND COGNITION IN A DIVERSE, LATE MIDDLE-AGED COHORT
Lijun An
Sweden
Abstract: BENCHMARKING THE AI-BASED DIAGNOSTIC POTENTIAL OF PLASMA PROTEOMICS FOR NEURODEGENERATIVE DISEASE IN 17,187 PEOPLE
Jonghyun Bae
United States
Abstract: LARGE-COHORT QUANTITATIVE SUSCEPTIBILITY MAPPING OF IRON ACCUMULATION IN ALZHEIMER’S DISEASE
Jiang Bian
China
Abstract: AN Α-SYNUCLEIN PET TRACER FOR DIAGNOSING PARKINSON’S DISEASE AND MULTIPLE SYSTEM ATROPHY
Baayla Boon
United States
Abstract: SPATIAL DYNAMICS OF AMYLOID-ΒETA CLEARANCE IN ADUCANUMAB-TREATED ALZHEIMER’S DISEASE
Joyce Ruifen Chong
Singapore
Abstract: INTEGRATING PLASMA BRAIN-DERIVED P-TAU217 (‘A’), WHITE MATTER HYPERINTENSITIES (‘V’) AND HIPPOCAMPAL (‘N’) VOLUMES IMPROVES PROGNOSTICATION IN A LARGE ASIAN COHORT
Marisa Denkinger
United States
Abstract: BRAIN-DERIVED P-TAU217 IN PLASMA SHOWS ENHANCED RESPONSE TO ALZHEIMER’S PATHOLOGY
Anna Dewenter
Germany
Abstract: MULTI-SPOT WHITE MATTER HYPERINTENSITIES: A PROGNOSTIC MARKER FOR CEREBRAL AMYLOID ANGIOPATHY PROGRESSION
Liliana German-Castelan
Canada
Abstract: CHOLINERGIC DYSFUNCTION MODULATES AGE-DEPENDENT MICROGLIAL RESPONSE IN ALZHEIMER’S DISEASE MODELS
Zhaoyuan Gong
United States
Abstract: AXONAL DEGENERATION OUTPERFORMS CSF AND PET BIOMARKERS IN TRACKING AND PREDICTING COGNITIVE DECLINE AND DEMENTIA RISK
Ryoji Goto
Japan
Abstract: NOVEL IMMUNOASSAY QUANTIFYING ACETYLATED ALPHA-SYNUCLEIN IN PLASMA PROVIDES HIGH DIAGNOSTIC PERFORMANCE FOR PARKINSON’S DISEASE
Laura Göschel
Germany
Abstract: LONGITUDINAL 7T MRS STUDY OF GLUTAMATE AND GABA DYNAMICS IN ALZHEIMER’S DISEASE PROGRESSION: FROM HYPER- TO HYPOEXCITATION
Aurélie Lebrun
Canada
Abstract: LONG-DISTANCE WHITE MATTER TRACT DAMAGE IN ALZHEIMERʼS DISEASE EMERGES AFTER TAU ACCUMULATION REACHES BRAAK STAGE III
Niels Okkels
Denmark
Abstract: BLOOD-BASED BIOMARKERS IN PRECLINICAL ALZHEIMER’S DISEASE: LONGITUDINAL TRAJECTORIES AND CLINICAL IMPACT IN A NATIONWIDE DANISH COHORT
Cathrine Sant
United States
Abstract: SINGLE-NUCLEUS MULTI-OMIC PROFILING OF APOE EFFECTS IN AD AND HEALTHY BRAIN AGING
Laura Stankeviciute
Sweden
Abstract: MODIFIABLE RISK FACTORS ARE ASSOCIATED WITH PLASMA AD BIOMARKERS AND DIGITAL COGNITION IN THE POPULATION-BASED STUDY REAL AD
Tal Tamir
Israel
Abstract: NEURAL CORRELATES OF THE IMPROVEMENT OF MOTOR AND NON-MOTOR SYMPTOMS IN PARKINSON’S DISEASE FOLLOWING A COMBINED DIGITAL AND LEVODOPA THERAPY
Giorgia Tosoni
Sweden
Abstract: CELLULAR AND MOLECULAR MAPPING OF ADULT HIPPOCAMPAL NEUROGENESIS IN ALZHEIMER’S DISEASE AND RESILIENCE
Yuto Uchida
United States
Abstract: QUANTIFICATION OF PERFORANT PATH FIBERS FOR EARLY DETECTION OF ALZHEIMER’S DISEASE
Alessandro Zilioli
Italy
Abstract: MRI-BASED ATROPHY SUBTYPES IN A YOUNG MEMORY CLINIC COHORT: ASSOCIATIONS WITH CLINICAL AND BIOMARKER PROFILES
Application is Now Closed.
For every edition of the AD/PD™ International Conference the Organizing Committee recognizes the top junior and trainee abstract presenters with Junior Faculty Awards*.
Recipients of this award will give an oral presentation on their research during the Conference.
The application deadline for the 2026 Junior Faculty Awards was September 17, 2025.
*Eligible candidates for the Junior Faculty Awards are graduate students (PhD, MD) or junior scientists up to five years after the doctorate degree (PhD, MD).
